Brief: Omega Therapeutics To Present Data From Early-To-Mid Stage Mychelangelo I Study
17/01/2023 12:12
Jan 17 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS TO PRESENT TRIAL-IN-PROGRESS POSTER FOR
PHASE
1/2 MYCHELANGELO™ I STUDY AT THE AMERICAN SOCIETY OF CLINICAL
ONCOLOGY GASTROINTESTINAL CANCERS SYMPOSIUM
Source text for Eikon: ID:nGNX6gyC8H
Further company coverage: OMGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence